Lisa Schlager

Guideline
Is the new Medicare NGS payment policy really a win for patients?
The implications of the new policy, however, are less positive than what appears at the surface. Patients seeking germline testing are only slightly better off now than they were two years ago, before the NCD was initiated.
February 4, 2020
2020 02 04 22 50 3305 Lab Pulse Second Opinion Logo Circlev2
Page 1 of 1
Top Stories
Dna Sequencing2 Social
Cancer
Invivoscribe, Complete Genomics partner to develop NGS tests for cancer research, detection
Under the terms of the deal, Invivoscribe will be responsible for the development of biomarker tests, including test controls and associated bioinformatics software. The tests will run on Complete Genomics' NGS platforms.
Test Tube Liquid Sample Social
Regulatory Approval
Seegene obtains IVDR certification for 30 diagnostic assays
Fda Button Social
Policy and Regulation
Advocacy groups in letter urge FDA to develop regulations for lab-developed tests
Scientists Collaborate Team Social
Collaboration
Nucleai, Adlai Nortye collaborate on biomarkers for clinical trials
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Home
Invivoscribe, Complete Genomics partner to develop NGS tests for cancer research, detection
Under the terms of the deal, Invivoscribe will be responsible for the development of biomarker tests, including test controls and associated bioinformatics software. The tests will run on Complete Genomics' NGS platforms.
June 2, 2023
Dna Sequencing2 Social
Seegene obtains IVDR certification for 30 diagnostic assays
The newly certified assays include eight for gastrointestinal infections, seven for women's diseases, five for respiratory diseases, four for tuberculosis, three for meningitis, two for human papillomavirus (HPV), and one for drug resistance.
June 1, 2023
Test Tube Liquid Sample Social
Advocacy groups in letter urge FDA to develop regulations for lab-developed tests
The FDA should use its authority to develop laboratory-developed test regulations if Congress does not pass legislation requiring it, said the Center for Science in the Public Interest and other organizations.
June 1, 2023
Fda Button Social
Nucleai, Adlai Nortye collaborate on biomarkers for clinical trials
The partnership will combine Nucleai's expertise in extracting and analyzing the quantitative spatial features of pathology images and Adlai Nortye's expertise in drug development and immunotherapy.
May 31, 2023
Scientists Collaborate Team Social
Long COVID symptoms reported by 17% of unvaccinated people
One in six unvaccinated people report persistent health impacts from COVID-19 two years after a confirmed SARS-CoV-2 infection.
June 1, 2023
Long Covid Word Cloud Social
One-third of U.S. adults with diabetes may have undetected cardiovascular disease
Researchers at Johns Hopkins University have generated evidence of how prevalent elevated levels of two biomarkers are in U.S. adults, with and without diabetes.
June 1, 2023
Heart Hologram Virtual Social
Serum assay may enable the diagnosis of neurodegenerative diseases
An assay that detects minute concentrations of alpha synuclein seeds in blood serum may enable quicker diagnosis of neurodegenerative disorders.
May 30, 2023
Blood Test Samples Lab Social
Asep Medical Holdings aims for Nasdaq listing
Sepset Biosciences, an Asep Medical business, is preparing for clinical studies aimed at the commercialization of a diagnostic test. The test leverages gene expression to predict the development of severe sepsis.
May 31, 2023
Earning Stock Market Social
Georgia doctor, clinics to pay $625K to resolve False Claims Act allegations
The defendants allegedly submitted improper claims to Medicare and Tricare insurance programs for evaluation and management services as well as medically unnecessary urine drug screening tests.
May 31, 2023
Gavel Money Social
Single-cell RNA sequencing data reveals T cells linked to cancer immunotherapy resistance
Scientists at the University of Texas MD Anderson Cancer Center have provided a new explanation for why checkpoint inhibitors are ineffective in some patients.
May 30, 2023
T Cell Social
Bacteria vary between early- and late-onset colorectal cancer tumors: Study
Bacteria types vary widely between early- versus late-onset colorectal cancer tumors, providing clues to the disease’s increase in younger people, according to a study.
May 30, 2023
Colorectal Cancer Social
At ASCO meeting, Veracyte highlights prostate cancer study data using genomics database
The Decipher GRID database, which is used by Veracyte and its partners in urologic cancer research, comprises more than 100,000 whole-transcriptome profiles from patients with urologic cancers.
May 30, 2023
Prostate Cancer 3 D Rendering Social
Page 1 of 53
Next Page